Javascript must be enabled to continue!
Reducing hERG Toxicity Using Reliable hERG Classification Model and Fragment Grow Model
View through CrossRef
Drug-induced cardiotoxicity has become one of the major reasons leading to drug withdrawal in past decades, which is closely related to the blockade of human Ether-a-go-go-related gene (hERG) potassium channel. Developing reliable hERG predicting model and optimizing model can greatly reduce the risk faced in drug discovery. In this study, we constructed eight hERG classification models, the best of which shows desirable generalization ability on low-similarity clinical compounds, as well as advantages in perceiving activity gap caused by small structural changes. Furthermore, we developed a hERG optimizer based on fragment grow strategy. Results reveal that after reinforcement learning, our model can provide reasonable optimizing direction to reduce hERG toxicity, especially when hERG risk is corresponding to lipophilicity, basicity and pi-pi interactions. We also prove its usage in helping chemists quickly pick out core fragments and fix on the region to be optimized. Overall, we demonstrate our model as a promising tool for medicinal chemists in hERG optimization attempts.
American Chemical Society (ACS)
Title: Reducing hERG Toxicity Using Reliable hERG Classification Model and Fragment Grow Model
Description:
Drug-induced cardiotoxicity has become one of the major reasons leading to drug withdrawal in past decades, which is closely related to the blockade of human Ether-a-go-go-related gene (hERG) potassium channel.
Developing reliable hERG predicting model and optimizing model can greatly reduce the risk faced in drug discovery.
In this study, we constructed eight hERG classification models, the best of which shows desirable generalization ability on low-similarity clinical compounds, as well as advantages in perceiving activity gap caused by small structural changes.
Furthermore, we developed a hERG optimizer based on fragment grow strategy.
Results reveal that after reinforcement learning, our model can provide reasonable optimizing direction to reduce hERG toxicity, especially when hERG risk is corresponding to lipophilicity, basicity and pi-pi interactions.
We also prove its usage in helping chemists quickly pick out core fragments and fix on the region to be optimized.
Overall, we demonstrate our model as a promising tool for medicinal chemists in hERG optimization attempts.
Related Results
hERG-LTN: A New Paradigm in hERG Cardiotoxicity Assessment Using Neuro-Symbolic and Generative AI Embedding (MegaMolBART, Llama3.2, Gemini, DeepSeek) Approach
hERG-LTN: A New Paradigm in hERG Cardiotoxicity Assessment Using Neuro-Symbolic and Generative AI Embedding (MegaMolBART, Llama3.2, Gemini, DeepSeek) Approach
Abstract
Assessing adverse drug reactions (ADRs) during drug development is essential for ensuring the safety of new compounds. The blockade of t...
Reducing hERG Toxicity Using hERG Classification Model and Fragment-growing Network
Reducing hERG Toxicity Using hERG Classification Model and Fragment-growing Network
Drug-induced cardiotoxicity has become one of the major reasons leading to drug withdrawal in past decades, which is closely related to the blockade of human Ether-a-go-go-relat...
CLOP-hERG: The Contrastive Learning Optimized Pre-trained Model for Representation Learning in Predicting Drug-Induced hERG Channel Blockers
CLOP-hERG: The Contrastive Learning Optimized Pre-trained Model for Representation Learning in Predicting Drug-Induced hERG Channel Blockers
During drug development, ensuring that drug molecules do not block the hERG (human Ether-à-go-go-Related Gene) channel is critical. If this channel is blocked, it can cause many ca...
Support Vector Machine model for hERG inhibitory activities based on the integrated hERG database using descriptor selection by NSGA-II
Support Vector Machine model for hERG inhibitory activities based on the integrated hERG database using descriptor selection by NSGA-II
AbstractAssessing the hERG liability in the early stages of drug discovery programs is important. The recent increase of hERG-related information in public databases enabled variou...
cAMP Performs a HERG-culean Task
cAMP Performs a HERG-culean Task
HERG, the pore-forming subunit of the rapidly activating delayed rectifier K
+
channel, is regulated by cAMP; however, the mechanism of control remains unkn...
Molecular Insights Into the Gating Kinetics of the Cardiac hERG Channel, Illuminated by Structure and Molecular Dynamics
Molecular Insights Into the Gating Kinetics of the Cardiac hERG Channel, Illuminated by Structure and Molecular Dynamics
The rapidly activating delayed rectifier K+ current generated by the cardiac hERG potassium channel encoded by KCNH2 is the most important reserve current for cardiac repolarizatio...
Therapeutic measures for COVID-19 and their clinical relevance of hERG channel translocation: A Pharmacodynamic approach
Therapeutic measures for COVID-19 and their clinical relevance of hERG channel translocation: A Pharmacodynamic approach
The COVID-19 caused by SARS-CoV-2 poses a massive challenge to the medical system, especially the safe and effective COVID-19 treatment methods, forcing people to look for drugs th...
Microfabricated Si Chips Containing Human Ether-a-Go-Go-Related Gene Channels As a Platform for Drug Safety Screenings
Microfabricated Si Chips Containing Human Ether-a-Go-Go-Related Gene Channels As a Platform for Drug Safety Screenings
Reconstitution of ion channel proteins in artificial bilayer lipid membranes (BLMs) provides an excellent system for drug screenings. However, the mechanical fragility of BLMs prev...

